Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766

ISSN： 1174-5886

Source： Drugs in R&D, Vol.7, Iss.5, 2006-01, pp. : 317-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trabectedin: ET 743, Ecteinascidin 743, Yondelis

Drugs in R&D, Vol. 4, Iss. 1, 2003-01 ,pp. : 75-81

Adis International

Access to resources Recommend Favorite

Ecteinascidin 743 [ET-743] may play an important role in the treatment of soft tissue sarcomas and other cancers

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

ET-743

By Cvetkovic R.S. Figgitt D.P. Plosker G.L.

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1185-1192

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Meta-Analysis of Trabectedin (ET-743, Yondelis ® ) in Cancer Patients

By Juan Jose Perez-Ruixo Zannikos Peter

Clinical Pharmacokinetics, Vol. 46, Iss. 10, 2007-01 ,pp. : 867-884

Adis International

Access to resources Recommend Favorite

Evaluation of Human Plasma Protein Binding of Trabectedin (Yondelis™, ET-743)

Current Clinical Pharmacology, Vol. 4, Iss. 1, 2009-01 ,pp. : 38-42

Bentham Science Publishers

Access to resources Recommend Favorite